1. | kurtisfatman | |
2. | BioElectrics007 | |
3. | matbust | |
4. | od2u | |
5. | rjmminiatures |
1. | kurtisfatman | |
2. | BioElectrics007 | |
3. | matbust | |
4. | od2u | |
5. | rjmminiatures |
1. | BioElectrics007 03/26/2018 Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD |
2. | matbust 03/05/2018 Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients |
3. | kurtisfatman 03/26/2018 CHANGE: 5.5 (34.4%) |
4. | BioElectrics007 05/08/2018 Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018 |
5. | kurtisfatman 02/14/2018 $33 PT |
6. | kurtisfatman 02/26/2018 Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017 |
7. | matbust 03/26/2018 just looking to make a quick buck here. |
8. | kurtisfatman 02/13/2018 Verona Pharma Provides Clinical Development Update |
9. | rjmminiatures 10/26/2018 Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma's RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference |
10. | kurtisfatman 08/01/2018 Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment |